This product was discontinued in June 2023. Please contact our helpful team if you have any questions.
PEA Liquid
Palmitoylethanolamide (PEA)
Serving Type: Oral Liquid
Available In Sizes: 100mL oral liquid
This product is intended for practitioner compounding only and is required to be dispensed by a qualified health professional.
(PEA) is an endogenous fatty acid amide analogue of the endocannabinoid anandamine, from the N-acylethanolamines family of lipid mediators.
Product Information
This product is intended for practitioner compounding only and is required to be dispensed by a qualified health professional.
- PEA is an endogenous fatty acid amide analogue of the endocannabinoid anandamine, from the N-acylethanolamines family of lipid mediators.
- PEA Liquid is micronised to a 20um-25um particle size using laser diffraction.
- Presented in a coconut-derived (MCT) lipid suspension for ease of compounding.
- 2mL contains 300mg PEA for easy dose calculation.
- Synthesised from palmitic acid from sustainably sourced palm oil, RSPO certified palm oil.
- PEA Liquid contains 99% pure PEA, which has been confirmed by purity testing.
- Low allergen, clean formula. Pleasant natural orange flavour.
Palmidrol (Palmitoylethanolamide ) | 300 mg |
In a base of medium chain triglycerides (fractioned coconut oil), ethanol and cold pressed orange oil.
For extemporaneous compounding by a qualified health professional.
INFORMATION FOR COMPOUNDING: 2 mL provides 300 mg of palmitoylethanolamide.
- KEEP OUT OF REACH OF CHILDREN.
- Compounding preparations should be supplied to an individual only after consultation with a health professional.
- It is required that a label is attached to the medicine providing instructions for use for that individual.
- Contains ethanol 6% v/v as a preservative.
- Do not use if seal on cap is broken.
- Shake well before use.
Practitioner Only